Search

ICADE.

Closed

SectorHealthcare

20.44 -0.29

Overview

Share price change

24h

Current

Min

20.22

Max

20.64

Key metrics

By Trading Economics

Income

3.7M

-92M

Sales

-126M

624M

EPS

-1.21

Dividend yield

20.41

Profit margin

-14.707

Employees

969

EBITDA

-95M

138M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+5.12% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

20.41%

2.33%

Market Stats

By TradingEconomics

Market Cap

-57M

1.6B

Previous open

20.73

Previous close

20.44

News Sentiment

By Acuity

50%

50%

165 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

ICADE. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 lis 2025, 23:51 UTC

Earnings

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 lis 2025, 23:10 UTC

Earnings

DBS Third Quarter Net Dips 2.0%

5 lis 2025, 22:55 UTC

Earnings

Arm Holdings 2Q Profit Climbs on Record Demand

5 lis 2025, 22:23 UTC

Earnings

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 lis 2025, 23:52 UTC

Earnings

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 lis 2025, 23:49 UTC

Earnings

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 lis 2025, 23:49 UTC

Earnings

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 lis 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 lis 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 lis 2025, 23:12 UTC

Earnings

Nutrien 3Q Adj EPS 97c >NTR.T

5 lis 2025, 23:11 UTC

Earnings

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 lis 2025, 23:10 UTC

Earnings

Nutrien 3Q Sales $6.01B >NTR.T

5 lis 2025, 23:10 UTC

Market Talk
Earnings

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 lis 2025, 23:10 UTC

Earnings

Nutrien 3Q EPS 96c >NTR.T

5 lis 2025, 23:04 UTC

Earnings

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 lis 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 lis 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 lis 2025, 22:55 UTC

Earnings

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 lis 2025, 22:51 UTC

Earnings

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 lis 2025, 22:50 UTC

Earnings

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 lis 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 lis 2025, 22:43 UTC

Market Talk
Earnings

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 lis 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 lis 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 lis 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 lis 2025, 22:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 lis 2025, 22:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 lis 2025, 22:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Responds to Delaware Chancery Court Ruling

5 lis 2025, 22:01 UTC

Earnings

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 lis 2025, 22:01 UTC

Earnings

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

ICADE. Forecast

Price Target

By TipRanks

5.12% upside

12 Months Forecast

Average 21.57 EUR  5.12%

High 25 EUR

Low 15.7 EUR

Based on 3 Wall Street analysts offering 12 month price targets forICADE. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

3 ratings

1

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

21.04 / 21.4Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

165 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.
help-icon Live chat